Pradaxa Lawsuit Updates
Higher Risk of Stomach Bleeding with Pradaxa Compared to Warfarin
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Higher Risk of Stomach Bleeding with Pradaxa Compared to Warfarin

By Jessica Tyner

 


Pradaxa Internal Bleeding LawsuitFor over 60 years, warfarin (also known as Coumadin) was the blood thinner of choice. It was effective, but it was also a hassle since it required close medical monitoring while being used. Sometimes it was a bit too effective, causing excessive bleeding, particularly in the stomach. This means immediate medical intervention was in order, and a healthcare professional had to administer the warfarin antidote. When Pradaxa came on the market, it was heavily pushed as a better alternative to warfarin because, according to the drug manufacturer, it didn't require medical monitoring.
 
However, that statement has been one of the pillars of the Pradaxa class action lawsuit as evidence has come to light that suggests that not only does Pradaxa have similar bleedout risks as warfarin, but there's also no antidote. The data and reports have been conflicting when it comes to bleeding problems, but federal drug regulators just issued a new statement in May 2014 that says Pradaxa side effects might have a bigger risk of stomach bleeding as compared to warfarin.

For many months, there have been claims that both warfarin and Pradaxa can cause stomach bleeding. However, this is the first time a federal agency has officially stated that Pradaxa may cause more bleeding than warfarin. The Food and Drug Administration (FDA) released the statement on May 13, 2014, saying that Pradaxa was linked with less risks of blood clot related strokes, including death and 'brain bleeds,' but there's a better chance of 'major' gastrointestinal bleeding. This information may be included in the blossoming Pradaxa class action lawsuits, especially as more Pradaxa victims come forward with stories. 

Read more: Higher Risk of Stomach Bleeding with Pradaxa Compared to Warfarin

 
Pradaxa Safety Results Changed in Study, Court Documents Reveal
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Pradaxa Safety Results Changed in Study, Court Documents Reveal

By Jessica Tyner

 


Pradaxa safetyBoehringer Ingelheim, makers of Pradaxa, is facing massive litigation over the safety of Pradaxa. A blood thinning medication, this drug was designed as an allegedly safer alternative to warfarin (otherwise known as Coumadin) which has been the staple blood thinner for over 60 years. However, it was recently revealed in court proceedings that Boehringer may have known all along that many patients may benefit from ongoing medical monitoring while taking Pradaxa, which has no antidote should internal bleeding occur.
 
Both warfarin and Pradaxa have been shown to cause excessive bleeding due their blood thinning properties. With warfarin, this is a commonly known issue and the warning labels recommend medical monitoring. If excessive bleeding does happen, it can be treated. With Pradaxa there is no antidote, and Boehringer specifically marketed the drug as easier than warfarin because it didn't require medical monitoring. That's what's at the heart of thousands of Pradaxa lawsuits. According to the latest court documents, Boehringer may have tried to cover up this Pradaxa bleeding risk in full drug clinical data.

Read more: Pradaxa Safety Results Changed in Study, Court Documents Reveal

 
Survivor of Pradaxa Bleeding Event Files Lawsuit
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Survivor of Pradaxa Bleeding Event Files Lawsuit

By Jessica Tyner

 

Pradaxa LawsuitWarfarin, also known as Coumadin, was the go-to source for blood thinning for decades because it was the only option. It was effective, but came with some complications. For example, it could cause excessive bleeding, but doctors had an antidote on hand in case that happened. It could also be cumbersome because it required close medical monitoring and lifestyle changes.

Once Boehringer Ingelheim Pharmaceuticals introduced Pradaxa to the market, however, that was supposed to be in the past. The new blood thinner was touted as just as safe, more effective, and easier to use as there were no lifestyle changes or medical monitoring required. However, soon after this new drug was available, Pradaxa complaints started to roll in.

Read more: Survivor of Pradaxa Bleeding Event Files Lawsuit

 
Documents Show Pradaxa Bleeding Risks Concealed from FDA
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Documents Show Pradaxa Bleeding Risks Concealed from FDA

By Jessica Tyner

 

Pradaxa Bleeding LawsuitAs the Pradaxa class action lawsuit moves forward, new documents showcase that Boehringer Ingelheim purposefully concealed the true bleeding risks from the Food and Drug Administration (FDA). The popular anti-coagulant was marketed as a new, better option for those who need blood thinners (most often to prevent strokes). Previously, Warfarin or Coumadin was the only drug for this purpose, but it demanded a change in diet and lifestyle. Pradaxa didn’t, but then Pradaxa lawsuits started coming. As lawsuits kept coming, it was revealed that there was a chance of excessive bleeding and even death from “bleed outs.” There was no antidote to this.

New documents in the Pradaxa litigation reveal that the makers weren’t forthcoming when revealing the Pradaxa side effects to the FDA. Boehringer Ingelheim is facing hundreds of Pradaxa victims and their heirs, all claiming that the company unnecessarily put lives on the line. Currently, there are over 2,000 Pradaxa complaints, with some heirs saying their loved ones blood to death from the drug.

Read more: Documents Show Pradaxa Bleeding Risks Concealed from FDA

 
Pradaxa Bleeding May be Fatal - Leads to Lawsuits
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Pradaxa Bleeding May be Fatal - Leads to Lawsuits

By Anne Bucher

 

Pradaxa bleeding lawsuitPradaxa (dabigatran etexilate) is a prescription blood-thinning medication that is used to reduce the risk of blood clots and strokes. Pradaxa was initially approved by the U.S. Food & Drug Administration (FDA) in 2010 to prevent strokes in patients with atrial fibrillation. It was a welcome alternative to the drug warfarin, which previously had been the drug of choice for patients with atrial fibrillation. Because Pradaxa requires less ongoing monitoring than warfarin, many doctors and patients preferred the convenience offered by Pradaxa.

Patients Complain of Pradaxa Bleeding Risks

As the popularity of Pradaxa increased, so did the number of reported injuries. The most common side effect of Pradaxa is bleeding. Pradaxa bleeding affects more than 10 percent of patients who take the drug. While the Pradaxa bleeding risk is similar to that of warfarin, warfarin bleeding can be reversed with vitamin K. Because there is currently no antidote to reverse Pradaxa bleeding, many physicians are concerned about the risk of death.

Read more: Pradaxa Bleeding May be Fatal - Leads to Lawsuits

 
More Articles...